How significant is the racial disparity in treating patients with skin cancer? Studies in recent years that suggest a troubling difference in the diagnosis and treatment some patients receive. We explore the significant impact this has on patient prognosis.
Mutation frequencies of EGFR and KRAS were 30 and 10 percent, respectively, and 23 and 13 percent, respectively, for Mexican and Colombian patients.
How effective is surgical treatment for ductal carcinoma in situ (DCIS) at preventing an invasive recurrence of breast cancer? Treatment is intended to significantly lessen the lifetime risk of breast cancer and breast cancer-related mortality, but are patients diagnosed with DCIS still at risk for experiencing poor outcomes? A recent study in JAMA Network Open…
Black race is associated with improved oncologic outcomes among men undergoing radiation-based therapy for high-risk prostate cancer, new findings suggest.
If, and to what degree, racial disparity in melanoma-specific survival (MSS) has persisted since 2010 was evaluated.
A significant amount of progress has been made in improving the treatment of lung cancer and patient outcomes. However, a number of disparities that can have an impact on these persist, including those affecting lung cancer screening. Lung cancer screening is an essential step toward effective treatment and improved survival, but its success depends on…
Efforts should be made to address patient concerns about clinical trial participation.
Among men on active surveillance or watchful waiting for low- and intermediate-risk prostate cancer (PCa), Blacks had a shorter median time from PCa diagnosis to definitive therapy compared with Whites.
A retrospective cohort study explored whether the low rate of resection for colorectal liver metastases is associated with lower survival rates among Black patients with CRC.
Link between Latino population, higher COVID-19 rates attenuated after adjustment for these factors
